Insider trading · Q3 2026 · CIK 1297184

Amphastar Pharmaceuticals, Inc. (AMPH) insider trading.

In Q3 2026, insiders at Amphastar Pharmaceuticals, Inc. reported 8 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $764K.

Transactions
8
Purchases (P)
0
Sales (S)
5
Net shares, P minus S
-33,479
Insiders
4
Last filed
2026-09-23

Insiders

InsiderRelationshipTransactionsBuysSales
Peters William JDirector, Officer · CFO, EVP & TREASURER302
Zhou RongOfficer · SENIOR EVP, PRODUCTION CENTER302
Prins Richard KDirector101
Pierce Anthony TDirector100

Transactions

8 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-21Peters William JS (D)4,139$25168,707Form 4
2026-09-16Zhou RongS (D)10,000$23.94169,203Form 4
2026-09-16Zhou RongM (A)10,000$13.35179,203Form 4
2026-09-02Zhou RongS (D)3,187$23.63169,203Form 4
2026-08-11Prins Richard KS (D)7,973$20.329,625Form 4
2026-08-07Peters William JM (A)5,053$19.79181,026Form 4
2026-08-07Peters William JS (D)8,180$22.48172,846Form 4
2026-07-09Pierce Anthony TA (A)7,886$07,886Form 4

Transaction codes in this quarter

Get AMPH insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1297184&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · AMPH company page · Amphastar Pharmaceuticals, Inc. on SEC.gov

Questions

Are insiders buying or selling Amphastar Pharmaceuticals, Inc. (AMPH)?

In Q3 2026, insiders at Amphastar Pharmaceuticals, Inc. reported 8 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $764K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Amphastar Pharmaceuticals, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/amph.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.